Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab with Chemoradiation for Esophageal Cancer (RTOG 0436)
NCT00655876Phase 3Completed
- Sponsor
- NRG Oncology
- Start
- Jun 2008
- Primary completion
- Apr 2015
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 3 trial of KL-140 in esophageal cancer, sponsored by NRG Oncology. Started Jun 2008; status: completed.
02
Drugs
KL-140
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00655876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00655876.